ATRA: Nilai perusahaan marang bathi resik atarabio.com
Atara Biotherapeutics (ATRA) is facing a shortage of rare reagents due to political tensions, which is hindering the certification of new drugs. Meanwhile, the business relies on an extensive network of US centers that ensures reliable transportation of biomaterials and high margins. The PE ratio is -5.90. The implementation of laboratory automation and data analysis software is made more evident by the daily price chart.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_ATRA_-_Atara-Biotherapeutics_-_PE-Multiple "ATRA: Periode bali modal bisnis Atara Biotherapeutics Inc 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Atara Biotherapeutics, Inc. (ATRA)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Atara Biotherapeutics|ATRA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Atara Biotherapeutics Inc|ATRA - Utang perusahaan|Rasio utang marang nilai buku Atara Bio|ATRA - Utang jangka dawa perusahaan|Utang jangka cendhak Atara Biotherapeutics|Rasio cepet atarabio.com
- rincian bathi lan kelipatan pasar:
ATRA - Penghasilan resik|Bathi resik mangsa ngarep Atara Biotherapeutics|ATRA - Pangali P/E|Pangali Forward P/E Atara Biotherapeutics Inc|ATRA - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Atara Bio|ATRA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Atara Biotherapeutics|ATRA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan atarabio.com|ATRA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Atara Biotherapeutics
Analisis komprehensif perusahaan:atarabio.com ATRA
Institutional capital evaluates Atara Biotherapeutics (ATRA) through the lens of the price-to-earnings ratio to determine the extent of the premium paid for future successes in cell therapy. By analyzing the P/E ratio dynamics of Atara Biotherapeutics (ATRA), investors can see how R&D biological risks impact the asset's fair value, allowing for an assessment of investment reliability regardless of economic cycles.
Pesaing wigati
Pangali P/E argenx.com|Koefisien rega marang bathi BNTX (BioNTech)|ABVX (ABIVAX) - Nilai perusahaan marang bathi resik|Pangali P/E ADMA (ADMA Bio)|Periode bali modal bisnis Protagonist Corp (PTGX)|IMVT - Rasio rega marang bathi|kiniksa.com (KNSA) - Koefisien rega marang bathi|Grifols (GRFS) - Rasio rega marang bathi|Koefisien rega marang bathi Adaptive Biotech|Koefisien rega marang bathi CLDX|Pangali P/E Aurinia Corp|Rasio rega marang bathi BioCryst (BCRX)|veratx.com - Pangali rega marang bathi|Pangali P/E DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalisasi marang bathi|AbCellera Bio - Pangali P/E|TRML - Pangali P/E|PGEN (Precigen, Inc.) - Koefisien rega marang bathi|PHAR: Rasio rega pasar marang bathi resik|NKTR (Nektar Therapeutics Inc.) - Pangali P/E|Pangali P/E Upstream Bio, Inc.|Rasio rega marang bathi Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Nilai perusahaan marang bathi resik|Pangali P/E GOSS (Gossamer Bio, Inc.)|Pangali P/E kalvista.com KALV|SEPN: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PVLA (Pieris Pharma)|SVRA: Pangali P/E|RIGL (Rigel Corp) - Rasio rega marang bathi|ANAB (AnaptysBio, Inc.) - Pangali P/E|astriatx.com (ATXS) - Periode bali modal bisnis|Rasio rega marang bathi enGene (ENGN)|RAPT - Kapitalisasi marang bathi|Aerovate Therapeutics - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics - Pangali P/E|Nilai perusahaan marang bathi resik TLSA (tizianalifesciences.com)|CABA: Pangali P/E|Kapitalisasi marang bathi Ventyx Biosciences Inc. (VTYX)|Rasio rega marang bathi Theratechnologies Inc|AVTX: Nilai perusahaan marang bathi resik|Pangali P/E ELDN|Pangali P/E agenusbio.com (AGEN)|Rasio rega marang bathi Climb Bio CLYM|ZURA (Zura Bio Ltd) - Kapitalisasi marang bathi resik|aTyr - Pangali P/E|Kapitalisasi marang bathi Adagene|IMA (ikenaoncology.com) - Koefisien rega marang bathi|Shattuck Labs (STTK) - Pangali P/E|Koefisien rega marang bathi EQ|CNTB (Connect Pharma) - Rasio rega pasar marang bathi resik|Pangali P/E IMUX|Periode bali modal bisnis inflarx.de|Pangali P/E XFOR (X4 Pharmaceuticals)|ACET - Koefisien rega marang bathi|CELU - Rasio rega marang bathi|Periode bali modal bisnis INmune Bio Inc INMB|BRNS: Pangali P/E|Kezar Life Sciences Inc (KZR) - Pangali P/E|Koefisien rega marang bathi SABS|AKTX (akaritx.com) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Nilai perusahaan marang bathi resik|Pangali P/E GOVX (GeoVax Labs Inc)|Pangali P/E Edesa Biotech Corp EDSA|IBIO - Rasio rega marang bathi|Kapitalisasi marang bathi resik CARM|XTLB: Pangali P/E|Bolt Biotherapeutics, Inc. - Nilai perusahaan marang bathi resik|HCWB (HCW Biologics, Inc.) - Pangali P/E|Pangali P/E Aptevo|Rasio rega marang bathi AIM ImmunoTech Inc. (AIM)|ADTX (aditxt.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi GRI Bio GRI|XRTX - Koefisien rega marang bathi|ReShape Lifesciences - Pangali P/E|REVB - Pangali P/E|INDP (Indaptus Therapeutics) - Koefisien rega marang bathi|scinai.com - Nilai perusahaan marang bathi resik|CALI (CalciMedica Inc) - Pangali P/E|Affimed Therapeutics (AFMD) - Periode bali modal bisnis|Rasio rega marang bathi Allakos Inc. (ALLK)|Koefisien rega marang bathi hookipapharma.com HOOK|Rasio rega marang bathi IGM Biosciences IGMS|ITOS - Koefisien rega marang bathi|OCEA: Koefisien rega marang bathi|TCBP - Pangali P/E|Third Harmonic Bio, Inc (THRD) - Rasio rega marang bathi
